Journals / Medicine Science / 2020 / Cilt: 9 - Sayı: 2

Synthesis and computer - aided drug design studies of novel thiosemicarbazide derivatives as potent and target - oriented anti - cancer agents

Pages
305–313
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the light of the results obtained from in silico studies, the title compounds displayed significant potential activity about possessing the qualification of being multi-target drugs by effecting and hitting a few of the main targets of cancer chemotherapy together and at the same time.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A series of novel thiosemicarbazide derivatives (2a-d) were synthesized from 3,5-bis(trifluoromethyl) benzohydrazide (1) and various substituted isothiocyanates.
📊
Key Findings & Data:The structures of novel compounds were determined by analytical and spectral (IR, 1H-NMR, and elemental analysis) methods.
💡
Conclusion & Impact:In the light of the results obtained from in silico studies, the title compounds displayed significant potential activity about possessing the qualification of being multi-target drugs by effecting and hitting a few of the main targets of cancer chemotherapy together and at the same time.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

A series of novel thiosemicarbazide derivatives (2a-d) were synthesized from 3,5-bis(trifluoromethyl) benzohydrazide (1) and various substituted isothiocyanates. The structures of novel compounds were determined by analytical and spectral (IR, 1H-NMR, and elemental analysis) methods. In silico studies were conducted to determine and evaluate the potential anticancer activity of the compounds. Target-oriented drug design is crucial for cancer therapy for increasing the selectivity and consequently decreasing the adverse effects of anticancer agents. Computer-aided drug design technology enables us to design and develop target-oriented and hence, selective therapeutic agents. We benefited that technology during our drug design process and selected our targets as ATP-dependent enzyme topoisomerase II (Topo II), epidermal growth factor receptor (EGFR) tyrosine kinase domain, carbonic anhydrase IX and tubulin-colchicine: stathmin-like domain complex, which has significant roles in the cancer development process by their biochemical and physiological activities. In the light of the results obtained from in silico studies, the title compounds displayed significant potential activity about possessing the qualification of being multi-target drugs by effecting and hitting a few of the main targets of cancer chemotherapy together and at the same time.

🔖

Cite This Article

DİNCEL, E. D., GÜZELDEMİRCİ, N. U. (2020). Synthesis and computer - aided drug design studies of novel thiosemicarbazide derivatives as potent and target - oriented anti - cancer agents. Medicine Science, Cilt: 9 - Sayı: 2, 305–313. https://ajindex.com/articles/276879

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Singhal S, Arora S, Agarwal S, et al. A review on potential biological activities of thiosemicarbazides. World J Pharm and Pharm Sci. 2013;2:4661-81
  2. Narang R, Narasimhan B, Sharma S. A review on biological activities and chemical synthesis of hydrazide derivatives. Curr Med Chem. 2012;19:569- 612
  3. Agata S, Staczek P, Stefańska J. Synthesis and structure-activity relationship studies of 4-arylthiosemicarbazides as topoisomerase IV inhibitors with grampositive antibacterial activity. Search for molecular basis of antibacterial activity of thiosemicarbazides. Eur J Med Chem. 2011;46:5717-26
  4. Patel DB, Patel KD, Prajapati NP, et al. Design, synthesis and biological in silico study of fluorine-containing quinoline hybrid thiosemicarbazide analogues J Heterocyc Chem. 2019;56:2235-52
  5. Pitucha M, Karczmarzyk Z, Swatko-Ossor M, et al. Synthesis, in vitro screening and docking studies of new thiosemicarbazide derivatives as antitubercular agents. Molecules. 2019;24:251
  6. Nevagi RJ, Dhake AS, Narkhede HI, et al. Design, synthesis and biological evaluation of novel thiosemicarbazide analogues as potent anticonvulsant agents. Bioorg Chem. 2014;54:68-72
  7. He J, Wang X, Zhao X, et al. Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety Eur J Med Chem. 2012;54:925-30. 8. Šarkanj B, Molnar M, Čačić M, et al. 4-Methyl-7-hydroxycoumarin antifungal and antioxidant activity enhancement by substitution with thiosemicarbazide and thiazolidinone moieties. Food Chem. 2013;139:488-95
  8. Matsa R, Makam P, Kaushik M, et al. Thiosemicarbazone derivatives: Design, synthesis and in vitro antimalarial activity studies. Eur J Pharm Sci. 2019;137:104986
  9. Ulusoy Güzeldemirci N, Cimok S, Daş-Evcimen N, et al. Synthesis and aldose reductase inhibitory effect of some new hydrazinecarbothioamides and 4-thiazolidinones bearing an imidazo[2,1-b]thiazole moiety. Turk J Pharm Sci. 2019;16:1-7
  10. Cihan-Üstündağ G, Gürsoy E, Naesens L, et al. Synthesis and antiviral properties of novel indole-based thiosemicarbazides and 4-thiazolidinones. Bioorg Med Chem. 2016;24:240-46
  11. Ulusoy Güzeldemirci N, Küçükbasmacı Ö. Synthesis and antimicrobial activity evaluation of new 1,2,4-triazoles and 1,3,4-thiadiazoles bearing imidazo[2,1-b]thiazole moiety. Eur J Med Chem. 2010;45:63-8
  12. Ulusoy Güzeldemirci N, Şatana D, Küçükbasmacı Ö. Synthesis, characterization, and antimicrobial evaluation of some new hydrazinecarbothioamide, 1,2,4